logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Ben Dake

This inventor holds 6 USPTO granted patents and 10 published patent applications. Top assignee: Aerovate Therapeutics, Inc.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ben Dake. Retrieved from https://idiyas.com/inventor/ben-dake

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal6 out of 6 
 
Aerovate Therapeutics, Inc.
 patents

Years Active: 2022-2023

Loading Chart...
6 patents (USPTO):Explore Patents
1. 11813263 - Inhalable imatinib formulations, manufacture, and uses thereof (2023-11-14),
2. 11806349 - Inhalable imatinib formulations, manufacture, and uses thereof (2023-11-07),
3. 11464776 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-10-11),
4. 11413289 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-08-16),
5. 11298355 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-04-12),
6. 11229650 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-01-25),

Title: The Innovative Journey of Ben Dake

Introduction

Ben Dake, an accomplished inventor based in Boston, MA, has made significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio consisting of six patents, he has focused on developing novel formulations that enhance therapeutic effectiveness and patient delivery methods.

Latest Patents

Among Ben's latest inventions is the patent for inhalable imatinib formulations. This invention relates to innovative methods of manufacturing and utilizing inhalable versions of imatinib, a medication commonly used in cancer treatment. The development of these formulations could significantly improve patient tolerance and accessibility to treatment.

Career Highlights

Currently, Ben Dake is a key member of Aerovate Therapeutics, Inc., where he applies his expertise in drug formulation and delivery. His work has positioned him as an influential figure in the pharmaceutical industry, particularly in respiratory therapy innovation.

Collaborations

Throughout his career, Ben has collaborated with talented individuals like Ralph Niven and Andrew D. Levin. These partnerships have not only enhanced his inventiveness but also fostered a creative environment that drives the advancement of cutting-edge therapeutic solutions.

Conclusion

In summary, Ben Dake stands out as a pioneering inventor in the pharmaceutical sector, with a strong focus on improving drug delivery systems. His ongoing work at Aerovate Therapeutics, alongside other brilliant minds, continues to pave the way for innovative treatments that prioritize patient care and clinical efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…